About Meda Pharma
Meda Pharma was founded in 1954 and is headquartered in Somerset, United States. Operations are centered on research and development within the pharmaceutical sector, with manufacturing of drugs targeted at various therapeutic areas. The company maintains a focus on producing medicinal products to address diverse health needs, supported by its domain medapharma.us for industry presence.
- Headquarter Somerset, United States
- SectorsHealthcare
- Website medapharma.us
- Social LinkedIn
- Acquired by The Carlyle Group (Sep 2001)
- Investors
- Acquired byThe Carlyle Group
(Sep 2001)
Investors in Meda Pharma
Meda Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Carlyle Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward multiple sectors. | 1986 | carlyle.com | - |
Investor details for Meda Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Meda Pharma
3 people are tracked at Meda Pharma (3 in leadership).
| Name | Role | Group |
|---|---|---|
Florin Rizea | CEO | Leadership |
Dennis Fuge | VP Manufacturing & Supply Chain | Leadership |
George Jacobson | Director, Consulting & Lending | Leadership |
Complete people profiles for Meda Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Meda Pharma
2 dated milestones of Meda Pharma across 47 years, from founding to its latest funding, stage changes and deals.
- Founded Meda Pharma is founded.
- Exit Acquired by The Carlyle Group.
Web traffic of Meda Pharma
Websites that share an audience with Meda Pharma (medapharma.us).
Websites whose visitors overlap most with Meda Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| makrocare.com | 100% | 6K | #4,487,196 | View details | |
| britannia-pharm.co.uk | 99% | 2K | #7,663,681 | View details | |
thoughtbroadcast.com | thoughtbroadcast.com | 67% | – | #11,647,247 | – |
| seaford.ca | 61% | 680.7K | #4,056,273 | View details | |
| carepharmaceuticals.com.au | 61% | 4.8K | #3,743,223 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Meda Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Meda Pharma
10 companies that operate in the same segment as Meda Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Meda Pharma
Meda Pharma was founded in 1954.
Meda Pharma is headquartered in Somerset, United States.
Meda Pharma was founded in 1954 and is headquartered in Somerset, United States. Operations are centered on research and development within the pharmaceutical sector, with manufacturing of drugs targeted at various therapeutic areas. The company maintains a focus on producing medicinal products to address diverse health needs, supported by its domain medapharma.us for industry presence.
Meda Pharma has 1 investor. Key investors include The Carlyle Group.
Yes. Meda Pharma was acquired by The Carlyle Group in September 2001.